AMETEK Announces Second Quarter Results

8/4/20

AMETEK, Inc. (NYSE: AME) today announced its financial results for the second quarter ended June 30, 2020.

AMETEK's second quarter 2020 sales were $1.01 billion, a 22% decline compared to the second quarter of 2019. Operating income in the quarter was $227.0 million and operating margins were 22.4%.

On a GAAP basis, second quarter earnings per diluted share were $0.72. Adjusted earnings were $0.84 per diluted share. Adjusted earnings adds back non-cash, after-tax, acquisition-related intangible amortization of $0.12 per diluted share. A reconciliation of reported GAAP results to adjusted results is included in the financial tables accompanying this release and on the AMETEK website.

"As we manage through the COVID-19 pandemic we continue to focus on the safety and well-being of all AMETEK colleagues. This remains our highest priority," said David A. Zapico, AMETEK Chairman and Chief Executive Officer.

"While our businesses were impacted by the pandemic during the second quarter, AMETEK colleagues rose to the challenge and delivered strong performance that exceeded expectations," added Mr. Zapico. "Our businesses were able to mitigate the impact of sales weakness with impressive operating execution resulting in record adjusted EBITDA margins at 28.6%."

"We further bolstered our already strong balance sheet and liquidity position with outstanding cash generation," Mr. Zapico continued. "Operating cash flow in the second quarter was $315 million, up 28% compared to the prior-year period, and free cash flow conversion was 183% of net income. AMETEK remains well positioned to continue to invest in our growth initiatives during this economic downturn while being positioned to deploy meaningful capital on acquisitions."

Electronic Instruments Group (EIG)
EIG sales in the second quarter were $647.9 million, down 21% from the same quarter in 2019. Operating income for EIG in the quarter was $159.6 million and operating income margins were 24.6%.

"EIG sales in the quarter were impacted by the global pandemic," noted Mr. Zapico. "However, our businesses delivered strong operating performance in the face of these difficult market conditions with excellent operating margins."

Electromechanical Group (EMG)
Second quarter sales for EMG were $364.0 million, down 22% versus the same quarter last year. EMG's second quarter operating income was $84.3 million and operating income margins were a record 23.2%.

"EMG drove outstanding operating performance in the quarter, despite lower sales due to the global pandemic. Through continued execution of Operational Excellence initiatives, EMG expanded operating margins by an impressive 170 basis points over last year's second quarter," commented Mr. Zapico.

2020 Outlook
"AMETEK navigated extremely well through a challenging quarter. Our flexible and proven operating model enabled us to deliver solid results while positioning us for robust growth coming out of the downturn. We have confidence in our ability to react to changing end market dynamics and deliver strong performance while continuing to invest in our long-term strategic initiatives," noted Mr. Zapico.

"Given the on-going uncertainty related to the spread of COVID-19 and the effect that may have across economies, we will not be providing guidance at this time," added Mr. Zapico. "We will provide forward guidance when visibility improves."

About AMETEK
AMETEK is a leading global manufacturer of electronic instruments and electromechanical devices with 2019 sales of approximately $5.0 billion. The AMETEK Growth Model integrates the Four Growth Strategies - Operational Excellence, New Product Development, Global and Market Expansion, and Strategic Acquisitions - with a disciplined focus on cash generation and capital deployment. AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. The common stock of AMETEK is a component of the S&P 500.

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.